MedTrace Logo

Chest Wall Motion Analysis in Disease

NCT02958683 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2019-02-22

No results posted yet for this study

Summary

Breathing movements, called chest wall motion, are very complex. The investigators are studying how movement of the abdomen, ribs and diaphragm contribute to breathing and how this differs with different diseases in the chest. Breathing movements may help with diagnosis, assessment of severity or assessing the impact of treatments for chest conditions. The investigators are following people who have a chest disease, measuring their chest wall motion and comparing it to their diagnosis and and how their treatment works.

Chest wall motion can be measured in different ways at rest and whilst exercising. Small stickers on the chest can be used to reflect infra red light or visible squares of light can be shone onto the chest without using stickers.

Conditions

  • Mesothelioma
  • Lung Neoplasms
  • Surgery
  • Cystic Fibrosis
  • Pectus Carinatum
  • Pectus Excavatum
  • Empyema, Pleural
  • Pulmonary Disease, Chronic Obstructive

Interventions

OTHER

Chest wall motion analysis

Assessment of chest wall motion using novel technologies including: optoelectronic plethysmography (OEP), structured light plethysmography (SLP), Microsoft Kinnect

Sponsors & Collaborators

  • University of Birmingham

    collaborator OTHER

  • University of Warwick

    collaborator OTHER

  • Heart of England NHS Trust

    lead OTHER

Principal Investigators

  • Babu Naidu, MBBS · Heart of England NHS Foundation Trust

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-07-31
Primary Completion
2015-07-31
Completion
2015-07-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02958683 on ClinicalTrials.gov